Value investors may be interested in the following three stocks since their share prices are trading below their respective Peter Lynch earnings lines, indicating they could be undervalued. Sell-side
Quest Diagnostics (DGX) signs agreement with Zora to develop cardiovascular mortality prediction test with the help of the latter's patented ceramide-analysis technology.
SECAUCUS, N.J. and HELSINKI, March 15, 2021 /PRNewswire/ -- Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throug

5 Undervalued Stocks With Profitable Business

04:08pm, Sunday, 14'th Mar 2021
According to the GuruFocus discounted cash flow calculator as of March 14, the following companies have a high margin of safety and have grown their margins over a 10-year period.
SECAUCUS, N.J., March 11, 2021 /PRNewswire/ -- At a virtual meeting with analysts and investors at its Investor Day, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX
SECAUCUS, N.J., and ST. LOUIS, March 8, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation's most highly integrat

Top 5 4th-Quarter Trades of Chris Davis' Firm

12:27pm, Friday, 26'th Feb 2021
Davis Select Advisors recently released its fourth-quarter 2020 portfolio update. Among the changes made during the quarter, the firm disclosed a new position in Viatris Inc. (NASDAQ:VTRS), a position
SECAUCUS, N.J., Feb. 24, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new COVID-19 testing service that aids
MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced an agreement with Quest Diagnostics (NYSE: DGX), t
SECAUCUS, N.J., Feb. 9, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host a virtual Investor Day for institutional investor
Quest Diagnostics Incorporated (DGX) CEO Steve Rusckowski on Q4 2020 Results - Earnings Call Transcript
Quest Diagnostics' (DGX) first-half 2021 outlook looks impressive thanks to strong revenue growth expectations.
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 4.67% and 2.25%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics Inc. said Thursday its board has approved a 10.7% increase in its quarterly dividend to 62 cents a share. The new dividend will be payable April 21 to shareholders of record as of Ap
SECAUCUS, N.J., Feb. 4, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the Company's Board of Directo
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE